These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6795623)

  • 1. ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type.
    Jaurin B; Grundström T
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):4897-901. PubMed ID: 6795623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of AmpC beta-lactamase (AmpCD) from an Escherichia coli clinical isolate with a tripeptide deletion (Gly286-Ser287-Asp288) in the H10 helix.
    Yamaguchi Y; Sato G; Yamagata Y; Doi Y; Wachino J; Arakawa Y; Matsuda K; Kurosaki H
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Jun; 65(Pt 6):540-3. PubMed ID: 19478427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional classification scheme for beta-lactamases and its correlation with molecular structure.
    Bush K; Jacoby GA; Medeiros AA
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1211-33. PubMed ID: 7574506
    [No Abstract]   [Full Text] [Related]  

  • 4. The E. coli beta-lactamase attenuator mediates growth rate-dependent regulation.
    Jaurin B; Grundström T; Edlund T; Normark S
    Nature; 1981 Mar; 290(5803):221-5. PubMed ID: 7010184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and for inhibitor design.
    Usher KC; Blaszczak LC; Weston GS; Shoichet BK; Remington SJ
    Biochemistry; 1998 Nov; 37(46):16082-92. PubMed ID: 9819201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cross-Validated Feature Selection (CVFS) approach for extracting the most parsimonious feature sets and discovering potential antimicrobial resistance (AMR) biomarkers.
    Yang MR; Wu YW
    Comput Struct Biotechnol J; 2023; 21():769-779. PubMed ID: 36698972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review on the mechanistic details of OXA enzymes of ESKAPE pathogens.
    Avci FG; Tastekil I; Jaisi A; Ozbek Sarica P; Sariyar Akbulut B
    Pathog Glob Health; 2023 May; 117(3):219-234. PubMed ID: 35758005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class C β-Lactamases: Molecular Characteristics.
    Philippon A; Arlet G; Labia R; Iorga BI
    Clin Microbiol Rev; 2022 Sep; 35(3):e0015021. PubMed ID: 35435729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights Into the Inhibition of MOX-1 β-Lactamase by S02030, a Boronic Acid Transition State Inhibitor.
    Ishikawa T; Furukawa N; Caselli E; Prati F; Taracila MA; Bethel CR; Ishii Y; Shimizu-Ibuka A; Bonomo RA
    Front Microbiol; 2021; 12():720036. PubMed ID: 34970229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a multiplex immunochromatographic assay for rapid identification of carbapenemases in a clinical microbiology laboratory: performance and turn-around-time evaluation of NG-test Carba 5.
    Yoon J; Kim CH; Yoon SY; Lim CS; Lee CK
    BMC Microbiol; 2021 Sep; 21(1):260. PubMed ID: 34587902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous Cleavages of a Heterologous Protein, the CenA Endoglucanase of
    Lai CY; Ng KL; Wang H; Lam CC; Wong WKR
    Microbiol Insights; 2021; 14():11786361211024637. PubMed ID: 34188486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial Resistance to Antimicrobial Agents.
    Varela MF; Stephen J; Lekshmi M; Ojha M; Wenzel N; Sanford LM; Hernandez AJ; Parvathi A; Kumar SH
    Antibiotics (Basel); 2021 May; 10(5):. PubMed ID: 34067579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of β-Lactamase-Producing Pathogens.
    Bush K; Bradford PA
    Clin Microbiol Rev; 2020 Mar; 33(2):. PubMed ID: 32102899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenemase-producing bacteria in food-producing animals, wildlife and environment: A challenge for human health.
    Bonardi S; Pitino R
    Ital J Food Saf; 2019 May; 8(2):7956. PubMed ID: 31316921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between β-lactamases and new β-lactamase inhibitors.
    Bush K; Bradford PA
    Nat Rev Microbiol; 2019 May; 17(5):295-306. PubMed ID: 30837684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Identification and Classification of β-Lactamases Based on Sequence Similarity Criteria: β-Lactamase Annotation.
    Silveira MC; Azevedo da Silva R; Faria da Mota F; Catanho M; Jardim R; R Guimarães AC; de Miranda AB
    Evol Bioinform Online; 2018; 14():1176934318797351. PubMed ID: 30210232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tackling the Antibiotic Resistance Caused by Class A
    Eiamphungporn W; Schaduangrat N; Malik AA; Nantasenamat C
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Past and Present Perspectives on β-Lactamases.
    Bush K
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases.
    Ur Rahman S; Ali T; Ali I; Khan NA; Han B; Gao J
    Biomed Res Int; 2018; 2018():9519718. PubMed ID: 29780833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing Genotype-to-Phenotype Relationships in Bacteria Causing Hospital-Acquired Pneumonia: A Prelude to the Application of Clinical Metagenomics.
    Ruppé E; Cherkaoui A; Lazarevic V; Emonet S; Schrenzel J
    Antibiotics (Basel); 2017 Nov; 6(4):. PubMed ID: 29186015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.